Waiting for the National Cholesterol Education Program Adult Treatment Panel IV Guidelines, and in the Meantime, Some Challenges and Recommendations

被引:31
作者
Martin, Seth S. [1 ]
Metkus, Thomas S. [1 ]
Horne, Aaron [1 ]
Blaha, Michael J. [1 ]
Hasan, Rani [1 ]
Campbell, Catherine Y. [1 ]
Yousuf, Omair [1 ]
Joshi, Parag [1 ]
Kaul, Sanjay [2 ]
Miller, Michael [3 ]
Michos, Erin D. [1 ]
Jones, Steven R. [1 ]
Gluckman, Ty J. [4 ]
Cannon, Christopher P. [5 ]
Sperling, Laurence S. [6 ]
Blumenthal, Roger S. [1 ]
机构
[1] Johns Hopkins Ciccarone Ctr Prevent Heart Dis, Baltimore, MD USA
[2] Cedars Sinai Med Ctr, Div Cardiovasc, Los Angeles, CA 90048 USA
[3] Univ Maryland, Sch Med, Div Cardiovasc, Baltimore, MD 21201 USA
[4] Providence Heart & Vasc Inst, Portland, OR USA
[5] Brigham & Womens Hosp, Div Cardiovasc, TIMI Study Grp, Boston, MA 02115 USA
[6] Emory Univ, Sch Med, Div Cardiovasc, Atlanta, GA USA
关键词
LOW-DENSITY-LIPOPROTEIN; ASSOCIATION TASK-FORCE; CARDIOVASCULAR-DISEASE; LDL CHOLESTEROL; APOLIPOPROTEIN-B; FOCUSED UPDATE; RISK; MANAGEMENT; ATHEROSCLEROSIS; METAANALYSIS;
D O I
10.1016/j.amjcard.2012.03.023
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The National Cholesterol Education Program Adult Treatment Panel (ATP) has provided education and guidance for decades on the management of hypercholesterolemia. Its third report (ATP III) was published 10 years ago, with a white paper update in 2004. There is a need for translation of more recent evidence into a revised guideline. To help address the significant challenges facing the ATP IV writing group, this statement aims to provide balanced recommendations that build on ATP III. The authors aim for simplicity to increase the likelihood of implementation in clinical practice. To move from ATP III to ATP IV, the authors recommend the following: (1) assess risk more accurately, (2) simplify the starting algorithm, (3) prioritize statin therapy, (4) relax the follow-up interval for repeat lipid testing, (5) designate <70 mg/di as an "ideal" low-density lipoprotein cholesterol target, (6) endorse targets beyond low-density lipoprotein cholesterol, (7) refine therapeutic target levels to the equivalent population percentile, (8) remove misleading descriptors such as "borderline high," and (9) make lifestyle messages simpler. In conclusion, the solutions offered in this statement represent ways to translate the totality of published reports into enhanced hyperlipidemia guidelines to better combat the devastating impact of hyperlipidemia on cardiovascular health. (C) 2012 Elsevier Inc. All rights reserved. (Am J Cardiol 2012;110:307-313)
引用
收藏
页码:307 / 313
页数:7
相关论文
共 30 条
[1]   2011 ACCF/AHA Focused Update Incorporated Into the ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction [J].
Anderson, Jeffrey L. ;
Adams, Cynthia D. ;
Antman, Elliott M. ;
Bridges, Charles R. ;
Califf, Robert M. ;
Casey, Donald E., Jr. ;
Chavey, William E. ;
Fesmire, Francis M. ;
Hochman, Judith S. ;
Levin, Thomas N. ;
Lincoff, A. Michael ;
Peterson, Eric D. ;
Theroux, Pierre ;
Wenger, Nanette Kass ;
Wright, R. Scott ;
Wright, R. Scott ;
Anderson, Jeffrey L. ;
Adams, Cynthia D. ;
Bridges, Charles R. ;
Casey, Donald E., Jr. ;
Ettinger, Steven M. ;
Fesmire, Francis M. ;
Ganiats, Theodore G. ;
Jneid, Hani ;
Lincoff, A. Michael ;
Peterson, Eric D. ;
Philippides, George J. ;
Theroux, Pierre ;
Wenger, Nanette K. ;
Zidar, James Patrick ;
Jacobs, Alice K. ;
Anderson, Jeffrey L. ;
Albert, Nancy ;
Hochman, Judith S. ;
Creager, Mark A. ;
Kushner, Frederick G. ;
Ettinger, Steven M. ;
Ohman, Erik Magnus ;
Guyton, Robert A. ;
Stevenson, William G. ;
Halperin, Jonathan L. ;
Yancy, Clyde W. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 57 (19) :E215-E367
[2]  
[Anonymous], NHANES 2007-2008 Laboratory Data
[3]   Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials [J].
Baigent, C. ;
Blackwell, L. ;
Emberson, J. ;
Holland, L. E. ;
Reith, C. ;
Bhala, N. ;
Peto, R. ;
Barnes, E. H. ;
Keech, A. ;
Simes, J. ;
Collins, R. .
LANCET, 2010, 376 (9753) :1670-1681
[4]   Apo B versus cholesterol in estimating cardiovascular risk and in guiding therapy: report of the thirty-person/ten-country panel [J].
Barter, PJ ;
Ballantyne, CM ;
Carmena, R ;
Cabezas, MC ;
Chapman, MJ ;
Couture, P ;
De Graaf, J ;
Durrington, PN ;
Faergeman, O ;
Frohlich, J ;
Furberg, CD ;
Gagne, C ;
Haffner, SM ;
Humphries, SE ;
Jungner, I ;
Krauss, RM ;
Kwiterovich, P ;
Marcovina, S ;
Packard, CJ ;
Pearson, TA ;
Reddy, KS ;
Rosenson, R ;
Sarrafzadegan, N ;
Sniderman, AD ;
Stalenhoef, AF ;
Stein, E ;
Talmud, PJ ;
Tonkin, AM ;
Walldius, G ;
Williams, KMS .
JOURNAL OF INTERNAL MEDICINE, 2006, 259 (03) :247-258
[5]   Screening for Cardiovascular Risk in Asymptomatic Patients [J].
Berger, Jeffrey S. ;
Jordan, Courtney O. ;
Lloyd-Jones, Donald ;
Blumenthal, Roger S. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 55 (12) :1169-1177
[6]   Associations between C-reactive protein, coronary artery calcium, and cardiovascular events: implications for the JUPITER population from MESA, a population-based cohort study [J].
Blaha, Michael J. ;
Budoff, Matthew J. ;
DeFilippis, Andrew P. ;
Blankstein, Ron ;
Rivera, Juan J. ;
Agatston, Arthur ;
O'Leary, Daniel H. ;
Lima, Joao ;
Blumenthal, Roger S. ;
Nasir, Khurram .
LANCET, 2011, 378 (9792) :684-692
[7]   Using pedometers to increase physical activity and improve health - A systematic review [J].
Bravata, Dena M. ;
Smith-Spangler, Crystal ;
Sundaram, Vandana ;
Gienger, Allison L. ;
Lin, Nancy ;
Lewis, Robyn ;
Stave, Christopher D. ;
Olkin, Ingram ;
Sirard, John R. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2007, 298 (19) :2296-2304
[8]   Lipoprotein management in patients with cardiometabolic risk - Consensus conference report from the American diabetes association and the American college of cardiology foundation [J].
Brunzell, John D. ;
Davidson, Michael ;
Furberg, Curt D. ;
Goldberg, Ronald B. ;
Howard, Barbara V. ;
Stein, James H. ;
Witztum, Joseph L. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 51 (15) :1512-1524
[9]   ESC/EAS Guidelines for the management of dyslipidaemias The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS) [J].
Catapano, Alberico L. ;
Reiner, Zeljko ;
De Backer, Guy ;
Graham, Ian ;
Taskinen, Marja-Riitta ;
Wiklund, Olov ;
Agewall, Stefan ;
Alegria, Eduardo ;
Chapman, M. John ;
Durrington, Paul ;
Erdine, Serap ;
Halcox, Julian ;
Hobbs, Richard ;
Kjekshus, John ;
Filardi, Pasquale Perrone ;
Riccardi, Gabriele ;
Storey, Robert F. ;
Wood, David .
ATHEROSCLEROSIS, 2011, 217 (01) :3-46
[10]   Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) [J].
Cleeman, JI ;
Grundy, SM ;
Becker, D ;
Clark, LT ;
Cooper, RS ;
Denke, MA ;
Howard, WJ ;
Hunninghake, DB ;
Illingworth, DR ;
Luepker, RV ;
McBride, P ;
McKenney, JM ;
Pasternak, RC ;
Stone, NJ ;
Van Horn, L ;
Brewer, HB ;
Ernst, ND ;
Gordon, D ;
Levy, D ;
Rifkind, B ;
Rossouw, JE ;
Savage, P ;
Haffner, SM ;
Orloff, DG ;
Proschan, MA ;
Schwartz, JS ;
Sempos, CT ;
Shero, ST ;
Murray, EZ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19) :2486-2497